Cytel

Cytel to Acquire SDS Life Science and SDS MedteQ to Enhance and Expand Thought-Leadership in Strategic Therapeutic Development

Pictured (from left to right): Albert Kim, Chief Medical Officer at Cytel, Joshua Schultz, CEO at Cytel. Anna Tˆrner, Founder of SDS Life Sciences and Maria Lundberg, CEO at SDS Life Science. Waltham, MA, October 13, 2022 - Cytel Inc., provider of quantitative insights and health data analytics to leaders in life sciences, has entered...

Cytel expansion unlocks innovative clinical development expertise for APAC biopharma sector

Waltham, MA, September 06, 2022 - Cytel Inc., a pioneer of adaptive clinical trial design and provider of advanced biometrics services, has expanded its operations into the Asia-Pacific region (APAC). This enables biotech and biopharma companies in APAC to have easier access to Cytelís established biometrics and advanced statistical solutions. For more than 35 years,...
1050 Winter St Suite 2700 Waltham, MA 02451 USA

+1 (617) 661-2011